Contact Raizner Slania Today & Start Building Your Case
Fill out this form to discuss your case with one of our experienced attorneys
or call us at
844-554-9099.
In 2002, C.R. Bard, a subsidiary of Johnson & Johnson, received FDA approval for its first Inferior Vena Cava Filter (IVC Filter), called the Bard Recovery Filter. The medical device was designed to prevent blood clots from the lower extremities from traveling to the lungs or heart, causing a pulmonary embolism. As early as 2004, the company began receiving complaints that its IVC Filters were causing serious complications including an increased risk of filter fracture, filter migration, and even death. Unfortunately, these devices were continually implanted in patients until 2005 when Bard voluntarily withdrew them from the market.
As the Bard Recovery Filter was withdrawn from the market in 2005, Bard received FDA approval for its G2 IVC Filter Systems, which it claimed had enhanced fracture resistance. These devices include the Bard G2 Filter and the Bard G2 Express Filter. However, the Bard G2 IVC Filter has proven to still have a heightened risk of fracturing. When pieces from the filter fracture off of the device, they often migrate throughout the body and embed themselves into the heart, lungs, or other organs. Because of this, only half of the fractured G2 IVC Filters can be successfully removed.
Patients who cannot have their Bard G2 IVC Filters remove can suffer from:
- Device migration
- Device erosion into the inferior vena cava
- Perforation
- Deep vein thrombosis (DVT)
- Bleeding
- Death
The FDA issued a notice to doctors in 2010, advising them not to leave retrievable IVC Filters in a patient’s body for extended periods of time. It wasn’t until 2014 that doctors were made aware of just how important the actual implantation timeframe is, when the FDA issued a safety statement advising the removal of IVC Filters between 29 and 54 days after implantation.
The first lawsuits regarding Bard’s IVC Filters were filed in 2012. The first of these went to trial in 2015 and was settled 10 days after the trial began. In August 2015, the remaining federal court Bard IVC Filter lawsuits were consolidated into multidistrict litigation in Arizona.
Bard IVC Filter Lawsuit Lawyers
If you or someone you know suffered serious complications or death after the implantation of a Bard IVC Filter, you may be eligible to receive compensation. Let the experienced medical device litigation attorneys at Raizner Slania evaluate your claim and fight for the compensation you deserve in a Bard IVC filter lawsuit. Contact Raizner Slania today for a free and confidential consultation.